Efficacy-based budget impact analysis of secukinumab vs adalimumab in the treatment of ankylosing spondylitis in finland

Authors
Category Primary study
JournalValue in Health
Year 2017
This article has no abstract
Epistemonikos ID: ecb5074a5da65d1af1bb8874ebff23322dbe613b
First added on: Feb 08, 2025